Hsv-1 And Hsv-2 Cns Nucleic-acid Based Panel

Device Code: 3562

Product Code(s): PGH

Definition: Intended For The Qualitative Detection And Differentiation Of HSV-1 And HSV-2 In Cerebrospinal Fluid (CSF) From Patients With Signs And Symptoms Of Herpes Simplex Virus (HSV) Central Nervous System (CNS) Infection. This Test Is An Aid In The Diagnosi

Device Classification Information

Device Type ID3562
Device NameHsv-1 And Hsv-2 Cns Nucleic-acid Based Panel
Physical StateReagent Assay Kit And Instrument
Technical MethodReal-time Polymerase Chain Reaction Assay
Target AreaNot Applicable, The Device Is An In Vitro Diagnostic Device
Regulation Medical SpecialtyMicrobiology
Review PanelMicrobiology
Premarket Review Office Of In Vitro Diagnostics And Radiological Health (OIR)
Submission Type510(k)
CFR Regulation Number866.3307 [🔎]
FDA Device ClassificationClass 2 Medical Device
Product CodePGH
GMP ExemptNo
Summary MRIneligible
Implanted DeviceNo
Life Support DeviceYes
Third Party Review Not Third Party Eligible

Recognized Standards

Total Product Life Cycle

Device Type ID3562
DeviceHsv-1 And Hsv-2 Cns Nucleic-acid Based Panel
Product CodePGH
FDA Device ClassificationClass 2 Medical Device
CFR Regulation Number866.3307 [🔎]
Premarket Reviews
ManufacturerDecision
FOCUS DIAGNOSTICS
 
GRANTED
1
 
SUBSTANTIALLY EQUIVALENT
1
Recalls
Manufacturer Recall Class Date Posted
1
Focus Diagnostics Inc
I Apr-02-2016
TPLC Last Update: 2019-04-02 20:32:26

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.